anti-Oncostatin M (OSM) Antikörper

anti-Oncostatin M Antikörper (OSM)
Auf finden Sie aktuell 208 Oncostatin M (OSM) Antikörper von 23 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen Oncostatin M Proteine (75) und Oncostatin M Kits (63) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 357 Oncostatin M Produkte verfügbar.
OncoM, OSM

Meistgesuchte Reaktivitäten zu anti-Oncostatin M (OSM) Antikörper

Wählen Sie die Spezies und Applikation aus

anti-Human Oncostatin M Antikörper:

anti-Mouse (Murine) Oncostatin M Antikörper:

anti-Rat (Rattus) Oncostatin M Antikörper:

Alle verfügbaren anti-Oncostatin M Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Am meisten referenzierte anti-Oncostatin M Antikörper

  1. Human Polyclonal Oncostatin M Primary Antibody für FACS, Neut - ABIN4899954 : Ohsaka, Hirota-Komatsu, Shibata, Ezaki, Shinohara, Yoshida: Specific association of increased vascular endothelial growth factor expression and its receptors with macrophage differentiation of HL-60 leukemia cells. in Biochemical and biophysical research communications 2008 (PubMed)
    Zeige alle 2 Referenzen für 4899954

  2. Human Polyclonal Oncostatin M Primary Antibody für ELISA (Detection), FACS - ABIN4899952 : Hurst, McLoughlin, Monslow, Owens, Morgan, Fuller, Topley, Jones: Secretion of oncostatin M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cells. in Journal of immunology (Baltimore, Md. : 1950) 2002 (PubMed)

  3. Human Monoclonal Oncostatin M Primary Antibody für IHC, IHC (p) - ABIN4341424 : Kang, Kim, Jang, Park, Lee, Kim: 22q11-q13 as a hot spot for prediction of disease-free survival in bile duct cancer: integrative analysis of copy number variations. in Cancer genetics 2014 (PubMed)

  4. Human Polyclonal Oncostatin M Primary Antibody für IHC, IHC (p) - ABIN4341425 : Guo, Chen, Shi, Wang, Chen, Diao, Hu, Yu, Qian, Guo: Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition. in Oncogene 2013 (PubMed)

Weitere Antikörper gegen Oncostatin M Interaktionspartner

Human Oncostatin M (OSM) Interaktionspartner

  1. Neutrophils are a major source of OSM-producing cells in patients with chronic rhinosinusitis and severe asthma.

  2. OSM and OSMR are highly expres (zeige TNF Antikörper)sed in inflammatory bowel disease intestinal mucosa compared to control mucosa. OSM promotes inflammatory behavior in human intestinal stroma.

  3. Study showed that in atrial fibrillation (AF) with thrombus, the atrial tissue infiltration of M1 macrophages increased significantly; the OSM expression was also found to increase simultaneously; downstream tissue factor (zeige F3 Antikörper) (TF) increased and tissue factor (zeige F3 Antikörper) pathway inhibitors (TFPI (zeige TFPI Antikörper))decreased, leading to an imbalance between TF and TFPI (zeige TFPI Antikörper) eventually. OSM might be related to thrombosis in patients with AF mediated by TF and TFPI (zeige TFPI Antikörper)

  4. a novel STAT3 (zeige STAT3 Antikörper)/SMAD3 (zeige SMAD3 Antikörper)-signaling axis is required for OSM-mediated senescence.

  5. This result demonstrates that HPV16 oncoproteins upregulate oncostatin M and play an important role to promote oral squamous cell carcinoma development

  6. The identification of the OSM inflammatory pathway as an important mediator of epithelial mesenchymal transition in triple-negative breast cancer (TNBC) may provide a novel potential opportunity to improve therapeutic strategies.

  7. Nucleolin (zeige NCL Antikörper) stabilizes oncostatin-M mRNA by binding to a GC-rich (zeige RELB Antikörper) element in its 3'UTR (zeige UTS2R Antikörper).

  8. Oncostatin M and interleukin-31 (zeige IL31 Antikörper): Cytokines, receptors, signal transduction and physiology.

  9. Oncostatin M can regulate airway smooth muscle responses alone or in synergy with IL-17A (zeige IL17A Antikörper).

  10. we demonstrated that recombinant human OSM (rhOSM) promoted tumor angiogenesis in EC cell lines by activating STAT3 (signal transducer and activator of transcription 3 (zeige STAT3 Antikörper)) and enhanced both cell migration and cell inva

Mouse (Murine) Oncostatin M (OSM) Interaktionspartner

  1. OSM mitigated the proliferation of Th17 cells and decreased the expression of IL-17 (zeige IL17A Antikörper) and IL-21 (zeige IL21 Antikörper); it promoted the activation of suppressor of cytokine signaling 3 (SOCS3 (zeige SOCS3 Antikörper)), STAT3 (zeige STAT3 Antikörper), and STAT5 (zeige STAT5A Antikörper); observations suggest that OSM can inhibit Th17 differentiation by reciprocally controlling SOCS3 (zeige SOCS3 Antikörper), STAT3 (zeige STAT3 Antikörper), and STAT5 (zeige STAT5A Antikörper)

  2. In an animal model of anti-TNF (zeige TNF Antikörper)-resistant intestinal inflammation, genetic deletion or pharmacological blockade of OSM significantly attenuates colitis.

  3. these results support the proinflammatory role of OSM when it is overexpressed in the skin. However, OSM expression was not required in the murine model of psoriasis induced by topical application of imiquimod, as demonstrated by the inflammatory phenotype of OSM-deficient mice or wild-type mice treated with anti-OSM antibodies.

  4. OSM (mOSM) signals mainly via an OSM receptor (OSMR (zeige OSMR PLURAL_@2410@))-gp130 (zeige LRPPRC PLURAL_@2410@) heterodimer and binds with only very low affinity to mLIFR.

  5. Loss of Oncostatin M Signaling in Adipocytes Induces Insulin (zeige INS Antikörper) Resistance and Adipose Tissue Inflammation in Vivo.

  6. mechanism of OSM-induced cardiomyocyte dedifferentiation is associated with B-Raf (zeige SNRPE Antikörper)/Mek (zeige MDK Antikörper)/Erk (zeige EPHB2 Antikörper) signaling pathway through the OSM receptor Obeta

  7. Oncostatin M and interleukin-31 (zeige IL31 Antikörper): Cytokines, receptors, signal transduction and physiology.

  8. OSM plays multiple critical roles in the maintenance and development of the hematopoietic microenvironment in the bone marrow at a steady state as well as after injury.

  9. OSM treatment preserved cardiac function, inhibited apoptosis and fibrosis, and stimulated angiogenesis via upregulating VEGF (zeige VEGFA Antikörper) and bFGF (zeige FGF2 Antikörper) in infarct border zone of ischemic myocardium, indicating that OSM could be a novel therapeutic target for MI.

  10. The mechanism of Oncostatin M on cardiac ischemia/reperfusion injury is partly mediated by the Notch3 (zeige NOTCH3 Antikörper)/Akt (zeige AKT1 Antikörper) pathway.

Cow (Bovine) Oncostatin M (OSM) Interaktionspartner

  1. Protein kinase R plays a pivotal role in oncostatin M and interleukin-1 signalling in bovine articular cartilage chondrocytes.

Oncostatin M (OSM) Antigen-Profil

Beschreibung des Gens

Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6. This gene encodes a growth regulator which inhibits the proliferation of a number of tumor cell lines. It regulates cytokine production, including IL-6, G-CSF and GM-CSF from endothelial cells.

Alternative names and synonyms associated with Oncostatin M (OSM)

  • oncostatin M (OSM) Antikörper
  • oncostatin M (Osm) Antikörper
  • oncostatin M-like (LOC100342491) Antikörper
  • oncostatin-M-like (LOC100152038) Antikörper
  • OncoM Antikörper
  • OSM Antikörper

Bezeichner auf Proteinebene für anti-Oncostatin M (OSM) Antikörper

oncostatin M , oncostatin-M

736338 Pan troglodytes
5008 Homo sapiens
18413 Mus musculus
289747 Rattus norvegicus
319086 Bos taurus
100724699 Cavia porcellus
611921 Canis lupus familiaris
101122466 Ovis aries
100342491 Oryctolagus cuniculus
100152038 Sus scrofa
Ausgewählte Anbieter für anti-Oncostatin M (OSM) Antikörper
Haben Sie etwas anderes gesucht?